Skip to content

SOLIS CLINICAL CONSULTING

Active
Private limited companyfounded 2023active for 3 yearsLangestraat(NEE) 19A, 3040 Huldenberg, BelgiumKBO/BCE: BE 0798.666.128

From the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

SOLIS CLINICAL CONSULTING has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €439,116 and a net result of €125,767. Equity has been growing by about 49% per year since 2023. Its solvency ranks better than 95% of 9,652 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 21-02-2023 Normal situation
Activity
Office administrative and support services NACE 82100and 1 other
Establishment unit
2.341.928.804 3040 Huldenberg, since 21-02-2023
Financial year end
31 December
Peppol
Reachable since 15-07-2024

Board and ownership

Board

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€166,804
▼ 32.6%
Turnover
≈ €290,000
estimated
Profit
€125,767
▼ 30.7%
Equity
€439,116
▲ 40.1%
Total assets
€462,828
▲ 43.4%
Filed on 23-03-2026, 130 days before the deadlinePDF
Score breakdownraises riskFounded in 2023lowers riskSector: Office administrative, office support and other business support activities (NACE 82)Figures for financial year 2025 (filed on 24-03-2026)Equity €439,116 (94.9% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 75% of micro companies in office administrative support (NACE 82)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 94.9% of total assets
Liquidity 57-8
short-term debt 5.1% · cash 5.6%
Profitability 100=
return on assets 27.2%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (12,668 companies, NACE 82, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.2%▲ +0.1 percentage points vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026highest value 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.1%▼ -0.1 percentage points vs 09-2026
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 17.76 (29.69 in 2024), above the usual 1.5. Short-term debt is 5.1% and cash 5.6% of total assets. 5.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 82, micro). It does better than 88% of them on solvency, 51% on liquidity, 87% on profitability and 76% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Office administrative, office support and other business support activities (NACE 82)
KBO
raises risk · Founded in 2023
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Figures for financial year 2025 (filed on 24-03-2026)
NBB · annual accounts
lowers risk · Equity €439,116 (94.9% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-03-2026, 130 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
130 days early
2024
42 days early
2023
41 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 71 days before the deadline. In the sector (NACE 82), the median for financial year 2024 was 7 days before the deadline, and 35% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 June (3 of the last 3 accounts filed within 88 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Positive: Higher solvency than 94% of companies in office administrative supportsector median 50.3% · 9,652 companies 94.9% View
  • Positive: Equity rose in 2025from €313,349 to €439,116 ▲ 40.1% View

Comparable companies

These companies have the same main activity as SOLIS CLINICAL CONSULTING: office administrative and support services (NACE 82100). They are comparable in size and age: total assets between €279,000 and €601,000, founded between 2021 and 2023.

CompanyTotal assetsGross margin
SOLIS CLINICAL CONSULTING Huldenberg€462,828€166,804
VANNIES Ichtegem€360,120€151,004
BOTINI Affligem€600,839€200,759
De Village Asse€319,467€126,564
AUROK Dilbeek€279,277€186,589
ADRESS & ADMINISTRATION MANAGEMENT SOLUTIONS Sint-Genesius-Rode€383,785€164,303
JVS Infra & Groen Merchtem€385,616€148,914
Full comparison

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about SOLIS CLINICAL CONSULTING

What is the company number of SOLIS CLINICAL CONSULTING?
The company number of SOLIS CLINICAL CONSULTING is 0798.666.128. The VAT number is the same number with BE in front: BE 0798.666.128.
Where is SOLIS CLINICAL CONSULTING based?
The registered office is at Langestraat(NEE) 19A, 3040 Huldenberg.Company details
What does SOLIS CLINICAL CONSULTING do?
According to the KBO register, the main activity is office administrative and support services (NACE 82100).
What is the legal form of SOLIS CLINICAL CONSULTING?
The legal form of SOLIS CLINICAL CONSULTING is Private limited company (BV).
When was SOLIS CLINICAL CONSULTING founded?
SOLIS CLINICAL CONSULTING was founded on 21-02-2023.
Is SOLIS CLINICAL CONSULTING still active?
Yes, SOLIS CLINICAL CONSULTING is an active enterprise in the KBO register.
What is the turnover of SOLIS CLINICAL CONSULTING?
The turnover in financial year 2025 is ≈ €290,000. This figure is estimated from the gross margin of €166,804 and 33 comparable companies (NACE 82). It probably lies between €210,000 and €430,000.Financials
Is SOLIS CLINICAL CONSULTING profitable?
In financial year 2025, SOLIS CLINICAL CONSULTING made a profit of €125,767.
Where can I find the annual accounts of SOLIS CLINICAL CONSULTING?
SOLIS CLINICAL CONSULTING filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of SOLIS CLINICAL CONSULTING due?
SOLIS CLINICAL CONSULTING must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.